Enzyme - EC
1.1.1.205 - IMP dehydrogenase |
|||||
|
|||||
Click on the
image to start downloading the PDB
file (tridimensional and interactive) |
|||||
|
|||||
EC |
1.1.1.205 |
||||
Official
Name |
IMP dehydrogenase |
||||
Alternative
name(s) |
Inosine-5'-monophosphate
dehydrogenase Inosinic acid dehydrogenase Inosinate dehydrogenase IMP oxidoreductase Inosine monophosphate oxidoreductase |
||||
Class |
1.Oxidoreductases 1.Acting on the CH-OH group of donors 1.With NAD+ or NADP+ as acceptor |
||||
Reaction
catalysed |
Inosine 5'-P
+ NAD+ + H2OXanthosine
5'-P + NADH |
||||
Substrates |
Inosine 5'-P NAD+ H2O |
||||
Products |
Xanthosine 5'-P NADH |
||||
Metabolic Pathways |
|||||
Other
comments |
The enzyme acts on the hydroxyl group of the hydrated derivative of the substrate. |
||||
IMP dehydrogenase catalyzes the rate-limiting reaction of de novo GTP biosynthesis, the NAD-dependent reduction of IMP into XMP. Inhibition of IMP dehydrogenase activity results in the cessation of DNA synthesis. As IMP dehydrogenase is associated with cell proliferation, it is a possible target for cancer chemotherapy. Mammalian and bacterial IMPDHs are tetramers of identical chains. There are two IMP dehydrogenase isozymes in humans. |
|||||
|